These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 25910482)

  • 41. The role of human papilloma virus (HPV) infection in non-anogenital cancer and the promise of immunotherapy: a review.
    Cobos C; Figueroa JA; Mirandola L; Colombo M; Summers G; Figueroa A; Aulakh A; Konala V; Verma R; Riaz J; Wade R; Saadeh C; Rahman RL; Pandey A; Radhi S; Nguyen DD; Jenkins M; Chiriva-Internati M; Cobos E
    Int Rev Immunol; 2014 Oct; 33(5):383-401. PubMed ID: 24811210
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The human papillomavirus (HPV)-related cancer biology: An overview.
    Araldi RP; Sant'Ana TA; Módolo DG; de Melo TC; Spadacci-Morena DD; de Cassia Stocco R; Cerutti JM; de Souza EB
    Biomed Pharmacother; 2018 Oct; 106():1537-1556. PubMed ID: 30119229
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevention and treatment of papillomavirus-related cancers through immunization.
    Frazer IH; Leggatt GR; Mattarollo SR
    Annu Rev Immunol; 2011; 29():111-38. PubMed ID: 21166538
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Telomerase Induction in HPV Infection and Oncogenesis.
    Katzenellenbogen R
    Viruses; 2017 Jul; 9(7):. PubMed ID: 28698524
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk factors inducing the persistence of high-risk genital papillomaviruses in the normal cervix.
    Vandenvelde C; Van Beers D
    J Med Virol; 1992 Nov; 38(3):226-32. PubMed ID: 1337551
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human papillomavirus in head and neck cancer: molecular biology and clinicopathological correlations.
    Szentirmay Z; Pólus K; Tamás L; Szentkuti G; Kurcsics J; Csernák E; Tóth E; Kásler M
    Cancer Metastasis Rev; 2005 Jan; 24(1):19-34. PubMed ID: 15785870
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer.
    Chelimo C; Wouldes TA; Cameron LD; Elwood JM
    J Infect; 2013 Mar; 66(3):207-17. PubMed ID: 23103285
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recent advances in the search for antiviral agents against human papillomaviruses.
    Fradet-Turcotte A; Archambault J
    Antivir Ther; 2007; 12(4):431-51. PubMed ID: 17668552
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidemiology and burden of HPV-related disease.
    Serrano B; Brotons M; Bosch FX; Bruni L
    Best Pract Res Clin Obstet Gynaecol; 2018 Feb; 47():14-26. PubMed ID: 29037457
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human papillomaviruses in cervical cancer I. HPV-16 and 18 predominate in the Greek population.
    Vassilandonopoulou G; Panotopoulou E; Fotiou S; Tserkezoglou A; Machera E; Kottaridis S
    Anticancer Res; 1997; 17(1A):117-20. PubMed ID: 9066640
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathology and epidemiology of HPV infection in females.
    Stanley M
    Gynecol Oncol; 2010 May; 117(2 Suppl):S5-10. PubMed ID: 20304221
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nature of cervical cancer and other HPV - associated cancers.
    Georgieva S; Iordanov V; Sergieva S
    J BUON; 2009; 14(3):391-8. PubMed ID: 19810128
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nanotechnology in the management of cervical cancer.
    Chen J; Gu W; Yang L; Chen C; Shao R; Xu K; Xu ZP
    Rev Med Virol; 2015 Mar; 25 Suppl 1():72-83. PubMed ID: 25752817
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Distinct geographic clustering of oncogenic human papillomaviruses multiple infections in cervical cancers: Results from a worldwide cross-sectional study.
    Pimenoff VN; Tous S; Benavente Y; Alemany L; Quint W; Bosch FX; Bravo IG; de Sanjosé S
    Int J Cancer; 2019 May; 144(10):2478-2488. PubMed ID: 30387873
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunity to oncogenic human papillomaviruses.
    Konya J; Dillner J
    Adv Cancer Res; 2001; 82():205-38. PubMed ID: 11447764
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Worldwide genetic variations in high-risk human papillomaviruses capsid L1 gene and their impact on vaccine efficiency.
    Oumeslakht L; Ababou M; Badaoui B; Qmichou Z
    Gene; 2021 May; 782():145533. PubMed ID: 33636291
    [TBL] [Abstract][Full Text] [Related]  

  • 57. KLF13 regulates the differentiation-dependent human papillomavirus life cycle in keratinocytes through STAT5 and IL-8.
    Zhang W; Hong S; Maniar KP; Cheng S; Jie C; Rademaker AW; Krensky AM; Clayberger C
    Oncogene; 2016 Oct; 35(42):5565-5575. PubMed ID: 27041562
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The impact of anti HPV vaccination on cervical cancer incidence and HPV induced cervical lesions: consequences for clinical management.
    Brinkman JA; Caffrey AS; Muderspach LI; Roman LD; Kast WM
    Eur J Gynaecol Oncol; 2005; 26(2):129-42. PubMed ID: 15857016
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Will vaccination against human papillomavirus prevent eye disease? A review of the evidence.
    Hughes DS; Powell N; Fiander AN
    Br J Ophthalmol; 2008 Apr; 92(4):460-5. PubMed ID: 18369059
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional variants of human papillomavirus type 16 demonstrate host genome integration and transcriptional alterations corresponding to their unique cancer epidemiology.
    Jackson R; Rosa BA; Lameiras S; Cuninghame S; Bernard J; Floriano WB; Lambert PF; Nicolas A; Zehbe I
    BMC Genomics; 2016 Nov; 17(1):851. PubMed ID: 27806689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.